A Pandemic We Can Prevent
Although antimicrobial resistance has been a known and growing problem for decades, only one new class of antibiotics has been discovered since 1984. Tackling AMR requires a fundamental change in how new antibiotics are valued, and government incentives that reward biotech firms for successfully developing them.
https://prosyn.org/XxwfTbZ
GENEVA – More than one in five Americans hospitalized with COVID-19 also contracts a bacterial infection. Absent effective antibiotics, those lucky enough to beat the coronavirus might die at the hands of these not-so-novel pathogens.